ALISSA STROJNY: Open Payments
NPI 1962630913 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,867 in 240 payments from 21 companies in 2025. Trend: 2023 $3,711 · 2024 $4,053 · 2025 $4,867
Food & beverage: $4,790Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 73 | $1,576 |
| Janssen Biotech, Inc. | 26 | $438 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 23 | $424 |
| GENZYME CORPORATION | 11 | $322 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $255 |
| Ardelyx, Inc. | 16 | $230 |
| Madrigal Pharmaceuticals | 12 | $212 |
| Gilead Sciences, Inc. | 8 | $207 |
| PFIZER INC. | 11 | $197 |
| Novo Nordisk Inc | 3 | $166 |
Products named: SKYRIZI, TREMFYA, RINVOQ, DUPIXENT, XIFAXAN, ENTYVIO, IBSRELA, REZDIFFRA.
Industry payments across SC — which companies pay providers there.
